The patient was a 44-year-old asymptomatic man with a round nodule observed in the left lung on a chest X-ray ([Picture A](#g001){ref-type="fig"}, arrow). Chest computed tomography revealed a well-circumscribed mass in the peripheral apico-posterior segment ([Picture B](#g001){ref-type="fig"}). A gross examination of the partially resected lung revealed a 2.0×2.0×1.8 cm, well-demarcated, tan-colored, solid tumor ([Picture C](#g001){ref-type="fig"}). Histopathologically, the tumor was composed of spindle cells arranged in fascicular or whorl fashion interspersed with collagens and psammomatous calcifications ([Picture D](#g001){ref-type="fig"}). Immunohistochemically, the tumor cells exhibited immunoreactivity for vimentin, EMA, progesterone receptor, and claudin-1 ([Picture D](#g001){ref-type="fig"}, inset). Magnetic resonance imaging revealed no cranial/spinal tumor. Thus, the tumor was diagnosed as primary pulmonary meningioma (PPM).

PPM is exceedingly rare but is now categorized as a distinct entity in the latest WHO classification of lung tumors, 2015. PPMs are nearly always benign ([@B1]). Worryingly, a high-uptake on fluorodeoxyglucose (FDG)-positron emission tomography (PET) is a feature of PPMs ([@B2]), which mimics malignancy and can lead to a misdiagnosis and overtreatment.
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